1BN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abitare In SpA

Watchlist Manager

Watchlist

Price: 2.73 EUR Market Closed

Market Cap: €69.8m

	Abitare In SpA F:1BN	IT
K	Kaken Pharmaceutical Co Ltd TSE:4521	JP
	Thinkpath Inc OTC:THPHF	CA
	Trinex Minerals Ltd ASX:TX3	AU
	Moringa Acquisition Corp NASDAQ:MACA	US
S	Soc Nat Proprietes d'Immeubles SCA PAR:MLPRI	FR

Profitability Summary

Abitare In SpA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-4%

Strong 3Y Average Gross Margin

57%

Declining Gross Margin

27% > -4%

Healthy Operating Margin

24%

Strong 3Y Average Operating Margin

57%

Operating Margin is Increasing

22% > 24%

Low Net Margin

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

13% > 0%

Negative Free Cash Flow Margin

-21%

Negative 3Y Average Free Cash Flow Margin

-89%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.